- For the maintenance treatment of asthma
- For maintenance treatment of chronic obstructive pulmonary disease (COPD)
$49 per month
- Asthma in adults and children 12 years and older
$49 per month
Most common
More serious
Most common
More serious
Serious interactions
Corticosteroids – dexamethasone, hydrocortisone, prednisolone
You should not use Wixela if you:
You should talk to your doctor before using Wixela if you:
You should not use Advair if you:
You should talk to your doctor before using Advair if you:
1 puff twice daily
Twice daily
60 powders, (100 mcg-50 mcg) will cost around $100
Advair HFA inhalation aerosol (CFC free 115 mcg-21 mcg/inh) will cost around $240
Wixela Inhub is the first FDA-approved generic version of Advair Diskus. Wixela Inhub and Advair Diskus are the brand names for these prescription drugs used for the treatment of asthma. They do not treat an acute asthma attack. You should use a rescue asthma inhaler, such as albuterol, for an acute attack.
Here we explain how these medications work, their similarities and differences, their side effects, and more. This should provide you with the basics to better understand your options.
Wixela Inhub is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Mylan Pharma. It contains fluticasone propionate an inhaled corticosteroid (ICS) and salmeterol xinafoate, a long-acting beta-agonist (LABA), also known as a bronchodilator. Wixela Inhub is used:
Wixela Inhub does not work right away and should not be used to relieve intense flare-ups of shortness of breath, sudden asthma attacks, or bronchospasm. If an asthma attack occurs, use your quick-relief inhaler.
In-vitro, pharmacokinetic, and clinical endpoint studies have shown the bioequivalence of Wixela Inhub 100/50 and Advair Diskus 100/50. Both drugs show significant improvement on FEV1 (forced expiratory volume in 1 second) lung function.
Wixela Inhub is available as a dry powder inhaler containing a combination of fluticasone propionate (100, 250, or 500 mcg) and salmeterol inhalation powder formulation for oral inhalation.
Wixela Inhub is used twice a day. The recommended starting dose is based on the severity of your asthma. Please read the full patient information leaflet and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Advair Diskus is an FDA (U.S. Food and Drug Administration) approved medication manufactured by GlaxoSmithKline (GSK). It is a prescription medication used to lessen and prevent the symptoms of asthma in adults and children 12 years of age and older. If you have asthma, your doctor may have prescribed Advair Diskus to you. It’s an aerosol medication you take by inhaling it into your airways and lungs using an inhaler, usually twice a day. It reduces inflammation and relaxes muscle tissue, helping to open up your airways and lungs, making it easier to breathe. This can give you daily relief from your asthma symptoms and make asthma attacks less likely.
Advair Diskus also contains the fluticasone propionate/salmeterol combination. When inhaled, these ingredients work together to open up your lungs and airways. Fluticasone propionate is a type of corticosteroid. When you inhale Advair Diskus, molecules of fluticasone propionate attach to areas on the surface of the cells in your airways and lungs called glucocorticoid receptors. This stimulates the receptors, making them produce lower amounts of the substances that trigger inflammation and greater amounts of anti-inflammatory proteins. This helps to reduce inflammation throughout your lungs and airways.
Salmeterol is a medication called a long-acting beta2-adrenergic agonist (LABA). It attaches to areas on the outside of muscle tissue in your airways and lungs called beta-2 receptors. This stimulates the receptors, causing them to relax the muscle tissue, opening up your lungs and airways.
Advair Diskus is available in an oral inhalation powder form, in the following doses: Fluticasone propionate (100, 250, or 500 mcg) and salmeterol (50 mcg) as an oral inhalation powder.
Advair Diskus is used twice a day. The recommended starting dose is based on the severity of your asthma. Please read the prescribing information leaflet and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
The most common side effects of Wixela Inhub in clinical trials compared to placebo include:
More serious side effects of Wixela Inhub include:
The most common side effects of Advair Diskus in clinical trials include:
More serious side effects of Advair Diskus include
These aren’t all the side effects Wixela Inhub or Advair Diskus can cause. You can find more details in the patient leaflet that comes with your medication. If you have any concerns about side effects, talk to your physician or a pharmacist.
Wixela Inhub can interact with other medications. These include:
Advair Diskus can interact with other medications. These include:
Wixela Inhub and Advair Diskus can interact with other medications. This can change how Wixela Inhub and Advair Diskus and other medications work and can make side effects more likely. Tell your prescribing physician about all your drugs, including vitamins and dietary supplements.
You should not use Wixela Inhub if you:
Talk to your doctor before using Wixela Inhub if you:
You should not use Advair Diskus if you:
Talk to your doctor before using Advair Diskus if you:
If you have any concerns about Wixela Inhub or Advair Diskus side effects, talk to your physician, or pharmacist for medical advice. Also inform your healthcare provider about any medical conditions, supplements, and over-the-counter meds you are taking. You are also encouraged to report side effects to the FDA: visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.